×
Entrez Id:
2064
Gene Symbol:
ERBB2
ERBB2
Mammary Neoplasms, Human
0.300
Therapeutic
CTD_human
Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer.
19436038
2009
×
Entrez Id:
2064
Gene Symbol:
ERBB2
ERBB2
Mammary Neoplasms, Human
0.300
Biomarker
CTD_human
Mouse breast cancer model-dependent changes in metabolic syndrome-associated phenotypes caused by maternal dioxin exposure and dietary fat.
18840765
2009
×
Entrez Id:
2064
Gene Symbol:
ERBB2
ERBB2
Mammary Neoplasms, Human
0.300
Therapeutic
CTD_human
Mouse breast cancer model-dependent changes in metabolic syndrome-associated phenotypes caused by maternal dioxin exposure and dietary fat.
18840765
2009
×
Entrez Id:
2064
Gene Symbol:
ERBB2
ERBB2
Mammary Neoplasms, Human
0.300
Biomarker
CTD_human
Relevance of breast cancer antiestrogen resistance genes in human breast cancer progression and tamoxifen resistance.
19075277
2009
×
Entrez Id:
2064
Gene Symbol:
ERBB2
ERBB2
Mammary Neoplasms, Human
0.300
Therapeutic
CTD_human
Neuregulin-1 attenuated doxorubicin-induced decrease in cardiac troponins.
19801490
2009
×
Entrez Id:
2064
Gene Symbol:
ERBB2
ERBB2
Mammary Neoplasms, Human
0.300
Therapeutic
CTD_human
Type 1 receptor tyrosine kinase profiles identify patients with enhanced benefit from anthracyclines in the BR9601 adjuvant breast cancer chemotherapy trial.
18768436
2008
×
Entrez Id:
2064
Gene Symbol:
ERBB2
ERBB2
Mammary Neoplasms, Human
0.300
Therapeutic
CTD_human
[Efficacy and toxicity of trastuzumab combined vinorelbine in 21 patients with HER2 overexpressing metastatic breast cancer].
18819904
2008
×
Entrez Id:
2064
Gene Symbol:
ERBB2
ERBB2
Mammary Neoplasms, Human
0.300
Biomarker
CTD_human
Type 1 receptor tyrosine kinase profiles identify patients with enhanced benefit from anthracyclines in the BR9601 adjuvant breast cancer chemotherapy trial.
18768436
2008
×
Entrez Id:
2064
Gene Symbol:
ERBB2
ERBB2
Mammary Neoplasms, Human
0.300
Biomarker
CTD_human
[Efficacy and toxicity of trastuzumab combined vinorelbine in 21 patients with HER2 overexpressing metastatic breast cancer].
18819904
2008
×
Entrez Id:
2064
Gene Symbol:
ERBB2
ERBB2
Mammary Neoplasms, Human
0.300
Therapeutic
CTD_human
CD40 signaling predicts response to preoperative trastuzumab and concomitant paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide in HER-2-overexpressing breast cancer.
18086299
2007
×
Entrez Id:
2064
Gene Symbol:
ERBB2
ERBB2
Mammary Neoplasms, Human
0.300
Biomarker
CTD_human
Trastuzumab plus vinorelbine or taxane chemotherapy for HER2-overexpressing metastatic breast cancer: the trastuzumab and vinorelbine or taxane study.
17614302
2007
×
Entrez Id:
2064
Gene Symbol:
ERBB2
ERBB2
Mammary Neoplasms, Human
0.300
Therapeutic
CTD_human
Trastuzumab plus vinorelbine or taxane chemotherapy for HER2-overexpressing metastatic breast cancer: the trastuzumab and vinorelbine or taxane study.
17614302
2007
×
Entrez Id:
2064
Gene Symbol:
ERBB2
ERBB2
Mammary Neoplasms, Human
0.300
Biomarker
CTD_human
CD40 signaling predicts response to preoperative trastuzumab and concomitant paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide in HER-2-overexpressing breast cancer.
18086299
2007
×
Entrez Id:
2064
Gene Symbol:
ERBB2
ERBB2
Mammary Neoplasms, Human
0.300
Therapeutic
CTD_human
Evaluation of the HER2/neu-derived peptide GP2 for use in a peptide-based breast cancer vaccine trial.
16596621
2006
×
Entrez Id:
2064
Gene Symbol:
ERBB2
ERBB2
Mammary Neoplasms, Human
0.300
Biomarker
CTD_human
Topoisomerase IIalpha gene amplification predicts favorable treatment response to tailored and dose-escalated anthracycline-based adjuvant chemotherapy in HER-2/neu-amplified breast cancer: Scandinavian Breast Group Trial 9401.
16682728
2006
×
Entrez Id:
2064
Gene Symbol:
ERBB2
ERBB2
Mammary Neoplasms, Human
0.300
Therapeutic
CTD_human
Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer.
16495393
2006
×
Entrez Id:
2064
Gene Symbol:
ERBB2
ERBB2
Mammary Neoplasms, Human
0.300
Biomarker
CTD_human
Evaluation of the HER2/neu-derived peptide GP2 for use in a peptide-based breast cancer vaccine trial.
16596621
2006
×
Entrez Id:
2064
Gene Symbol:
ERBB2
ERBB2
Mammary Neoplasms, Human
0.300
Biomarker
CTD_human
Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer.
16495393
2006
×
Entrez Id:
2064
Gene Symbol:
ERBB2
ERBB2
Mammary Neoplasms, Human
0.300
Therapeutic
CTD_human
Topoisomerase IIalpha gene amplification predicts favorable treatment response to tailored and dose-escalated anthracycline-based adjuvant chemotherapy in HER-2/neu-amplified breast cancer: Scandinavian Breast Group Trial 9401.
16682728
2006
×
Entrez Id:
2064
Gene Symbol:
ERBB2
ERBB2
Mammary Neoplasms, Human
0.300
Biomarker
CTD_human
Efficacy of high-dose alkylating chemotherapy in HER2/neu-negative breast cancer.
16446318
2006
×
Entrez Id:
2064
Gene Symbol:
ERBB2
ERBB2
Mammary Neoplasms, Human
0.300
Biomarker
CTD_human
Investigating the combination of trastuzumab and HER2/neu peptide vaccines for the treatment of breast cancer.
16865596
2006
×
Entrez Id:
2064
Gene Symbol:
ERBB2
ERBB2
Mammary Neoplasms, Human
0.300
Therapeutic
CTD_human
Efficacy of high-dose alkylating chemotherapy in HER2/neu-negative breast cancer.
16446318
2006
×
Entrez Id:
2064
Gene Symbol:
ERBB2
ERBB2
Mammary Neoplasms, Human
0.300
Biomarker
CTD_human
Metastatic breast cancer: an updating.
16950593
2006
×
Entrez Id:
2064
Gene Symbol:
ERBB2
ERBB2
Mammary Neoplasms, Human
0.300
Biomarker
CTD_human
Trastuzumab in combination with metronomic cyclophosphamide and methotrexate in patients with HER-2 positive metastatic breast cancer.
16978400
2006
×
Entrez Id:
2064
Gene Symbol:
ERBB2
ERBB2
Mammary Neoplasms, Human
0.300
Therapeutic
CTD_human
Investigating the combination of trastuzumab and HER2/neu peptide vaccines for the treatment of breast cancer.
16865596
2006